Huida Gene: US FDA grants rare paediatric disease designation to HuidaGene's HG004 to treat inherited blindness

HuidaGene Therapeutics (HuidaGene), a clinical─stage biotechnology company focused on developing CRISPR─based programmable genomic medicines, announced the US Food and Drug Administration (FDA)